{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:06:30Z","timestamp":1772168790900,"version":"3.50.1"},"update-to":[{"DOI":"10.12688\/f1000research.130169.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000}}],"reference-count":43,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Kawasaki disease is an acute, febrile disease that is not typically fatal if treated and affects infants and children more commonly. More than 80% of the afflicted patients are under the age of four. This disease most commonly affects coronary arteries. In a minority of cases, Aneurysms can burst or produce thrombosis, and they can cause infarction. The distinctive redness in the palms and soles of the feet might result from a delayed-type hypersensitivity reaction to a cross-reactive or recently discovered antigen (s). Autoantibodies against epithelial cells and smooth muscle cells are produced as a result of subsequent macromolecule synthesis and polyclonal white blood cell activation, which intensifies the redness. Kawasaki disease's clinical manifestations range from oral skin disease to the blistering of the mucosa, symptoms involving the hands and the feet, skin disease of the palms and soles, a desquamative rash, and cervical lymphatic tissue enlargement (so it is also referred to as tissue layer lymphatic tissue syndrome). Most untreated patients develop some vessel sequelae, from well-organized coronary inflammation to severe arterial blood vessel dilatation to giant artery aneurysms with rupture or occlusion, infarction, and thrombosis. With human gamma globulin administration, reasonable standards of medical care, and the use of analgesics, the speed of symptomatic progression and inflammatory artery changes are reduced. In this review, we have covered the immunology of Kawasaki disease, its biomarkers, and the neurological manifestations of this multisystem illness. We have also included a discussion on its pathogenesis, diagnosis, and treatment.<\/ns4:p>","DOI":"10.12688\/f1000research.130169.2","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T13:15:07Z","timestamp":1680527707000},"page":"235","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates"],"prefix":"10.12688","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-263X","authenticated-orcid":false,"given":"Omniat","family":"Amir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-1829","authenticated-orcid":false,"given":"Priyadarshi","family":"Prajjwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pugazhendi","family":"Inban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-1207","authenticated-orcid":false,"given":"Srikanth","family":"Gadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Aleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayyan Rafik","family":"Sunasra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Elhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omklthoum","family":"Alsir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12969-021-00601-6","article-title":"Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial.","volume":"19","author":"S Fukui","year":"2021 Jul 3","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"108385","DOI":"10.1016\/j.clim.2020.108385","article-title":"A framework for understanding Kawasaki disease pathogenesis.","volume":"214","author":"M Lo","year":"2020 May","journal-title":"Clin. Immunol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"20-22","DOI":"10.1111\/j.1365-2249.2011.04361.x","article-title":"Pathogenesis of Kawasaki disease.","volume":"164","author":"K Takahashi","year":"2011 May","journal-title":"Clin. Exp. Immunol."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14740\/cr993","article-title":"Global Burden and Genetic Background.","volume":"11","author":"K Elakabawi","year":"2020","journal-title":"Cardiol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"666-669","DOI":"10.1542\/peds.84.4.666","article-title":"Kawasaki disease in families.","volume":"84","author":"Y Fujita","year":"1992 Oct","journal-title":"Pediatrics."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"41-e45","DOI":"10.5114\/amsad.2018.74522","article-title":"Kawasaki disease: a comprehensive review.","volume":"3","author":"K Ramphul","year":"2018 Mar 21","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"391-405","DOI":"10.1038\/s41584-020-0426-0","article-title":"Kawasaki disease: pathophysiology and insights from mouse models.","volume":"16","author":"M Noval Rivas","year":"2020 Jul","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/ijms20081834","article-title":"B Cells and Antibodies in Kawasaki Disease.","volume":"20","author":"M Lindquist","year":"2019 Apr 13","journal-title":"Int. J. Mol. Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1738-1749","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki Disease.","volume":"67","author":"J Newburger","year":"2016 Apr 12","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"940-943","DOI":"10.1086\/323155","article-title":"CD8 T Lymphocytes and Macrophages Infiltrate Coronary Artery Aneurysms in Acute Kawasaki Disease.","volume":"184","author":"T Brown","year":"1 October 2001","journal-title":"J. Infect. Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"15-21","DOI":"10.3349\/ymj.2016.57.1.15","article-title":"Recent Advances in Kawasaki Disease.","volume":"57","author":"K Kim","year":"2016 Jan","journal-title":"Yonsei Med. J."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"759-772","DOI":"10.3349\/ymj.2006.47.6.759","article-title":"Kawasaki disease.","volume":"47","author":"D Kim","year":"2006 Dec 31","journal-title":"Yonsei. Med. J."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e142-e143","DOI":"10.1097\/RHU.0000000000001024","article-title":"An Adult With Fever and Facial Nerve Palsy: An Unusual Presentation of Kawasaki Disease.","volume":"26","author":"A Jindal","year":"2020 Aug","journal-title":"J. Clin. Rheumatol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"605-608","DOI":"10.1016\/j.braindev.2011.09.015","article-title":"Kawasaki disease-associated MERS: pathological insights frfr SPECT findings.","volume":"34","author":"T Sato","year":"2012","journal-title":"Brain and Development."},{"key":"ref15","first-page":"24201-24204","article-title":"Facial Nerve Paralysis- Rare Neurological Complication of Kawasaki Disease.","volume":"31","author":"M Sun","year":"2020 October","journal-title":"Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/adc.79.2.e198","article-title":"Neurological complications of Kawasaki disease.","volume":"79","author":"D McDonald","year":"1998 Aug","journal-title":"Arch. Dis. Child."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"598867","DOI":"10.3389\/fped.2021.598867","article-title":"Kawasaki Disease Complicated by Late-Onset Fatal Cerebral Infarction: A Case Report and Literature Review.","volume":"9","author":"L Wang","year":"2021 May 19","journal-title":"Front. Pediatr."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1160-1163","DOI":"10.1111\/dmcn.12002","article-title":"Cerebral vasculitis in severe Kawasaki disease: early detection by magnetic resonance imaging and good outcome after intensive treatment.","volume":"54","author":"C Gitiaux","year":"2012 Dec","journal-title":"Dev. Med. Child Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12969-020-00452-7","article-title":"Neurological involvement in Kawasaki disease: a retrospective study.","volume":"18","author":"X Liu","year":"2020 Jul 14","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"640-646","DOI":"10.1136\/archdischild-2018-315087","article-title":"Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.","volume":"104","author":"R Tulloh","year":"2019 Jul","journal-title":"Arch. Dis. Child."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8-13","DOI":"10.1515\/med-2020-0002","article-title":"A Combination Therapy for Kawasaki Disease with Severe Complications: a Case Report.","volume":"15","author":"Y Abe","year":"2019 Dec 26","journal-title":"Open Med (Wars)."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1911-1920","DOI":"10.1016\/j.jacc.2009.04.102","article-title":"When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.","volume":"54","author":"J Gordon","year":"2009 Nov 17","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"444-446","DOI":"10.1007\/s00246-012-0285-9","article-title":"Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.","volume":"34","author":"K Sivakumar","year":"2013 Feb","journal-title":"Pediatr. Cardiol."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00011","article-title":"Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne.","volume":"7","author":"M Harpe","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1296-1299","DOI":"10.1097\/INF.0000000000000449","article-title":"A study of cardiovascular miRNA biomarkers for Kawasaki disease.","volume":"33","author":"A Rowley","year":"2014 Dec","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref26","article-title":"Biomarkers for Kawasaki Disease:Clinical Utility and the Challenges Ahead Himanshi Chaudhary, Johnson Nameirakpam, Rajni Kumrah, Vignesh Pandiarajan,Deepti Suri, Amit Rawat and Surjit Singh."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12887-021-03003-5","article-title":"CASP5 and CR1 as potential biomarkers for Kawasaki disease: an Integrated Bioinformatics-Experimental Study.","volume":"21","author":"Y Rahmati","year":"2021","journal-title":"BMC Pediatr."},{"key":"ref28","first-page":"A35","article-title":"Tulloh RG85(P) Admissions to hospital and awareness of kawasaki disease in england.","volume":"103","author":"A George","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"43732","DOI":"10.1038\/srep43732","article-title":"Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis.","volume":"7","author":"Y Kimura","year":"2017 Mar 6","journal-title":"Sci. Rep."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"977-983","DOI":"10.1253\/circj. CJ-20-1271","article-title":"Soluble LR11 as a Novel Biomarker in Acute Kawasaki Disease.","volume":"86","author":"K Watanabe","year":"2022 May 25","journal-title":"Circ. J."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"265-275","DOI":"10.1002\/2211-5463.12563","article-title":"New biomarkers of Kawasaki disease identified by urine proteomic analysis.","volume":"9","author":"H Hu","year":"2018 Dec 20","journal-title":"FEBS Open Bio."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"267-274","DOI":"10.5114\/aoms\/144293","article-title":"The clinical implications of serum ferritin in Kawasaki disease: a helpful biomarker for evaluating therapeutic responsiveness, coronary artery involvement and the tendency of macrophage activation syndrome.","volume":"18","author":"Z Qiu","year":"2021 Dec 8","journal-title":"Arch. Med. Sci."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e014569","DOI":"10.1161\/JAHA.119.014569","article-title":"Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction.","volume":"9","author":"S Hoshino","year":"2020 Jan 7","journal-title":"J. Am. Heart Assoc."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3058-3068","DOI":"10.1016\/j.csbj.2021.05.036","article-title":"A computational workflow for the detection of candidate diagnostic biomarkers of Kawasaki disease using time-series gene expression data.","volume":"19","author":"V Pezoulas","year":"2021 May","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"391-405","DOI":"10.1038\/s41584-020-0426-0","article-title":"Kawasaki disease: pathophysiology and insights from mouse models.","volume":"16","author":"M Noval Rivas","year":"2020 Jul","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e20183675","DOI":"10.1542\/peds.2018-3675","article-title":"Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.","volume":"143","author":"M Portman","year":"2019 Jun","journal-title":"Pediatrics."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e005370","DOI":"10.1161\/JAHA.116.005370","article-title":"Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.","volume":"6","author":"E Nanishi","year":"2017 Jul 6","journal-title":"J. Am. Heart Assoc."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"852-861","DOI":"10.1016\/S2352-4642(21)00270-4","article-title":"Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.","volume":"5","author":"J Burns","year":"2021 Dec","journal-title":"Lancet Child Adolesc Health."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"801-805","DOI":"10.7499\/j.issn.1008-8830.2019.08.012","article-title":"Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small\/medium-sized coronary artery aneurysms.","volume":"21","author":"Y Liu","year":"2019 Aug","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"107-117.e12","DOI":"10.1016\/j.jpeds.2019.07.064","article-title":"Phase I\/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm.","volume":"215","author":"A Tremoulet","year":"2019 Dec","journal-title":"J. Pediatr."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1379-1385","DOI":"10.1161\/01.cir.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.","volume":"94","author":"H Kato","year":"1996 Sep 15","journal-title":"Circulation."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1116-1120","DOI":"10.1016\/s0002-9149(98)00116-7","article-title":"A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.","volume":"81","author":"A Beiser","year":"1998 May 1","journal-title":"Am. J. Cardiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"233-235","DOI":"10.1007\/s00381-020-04784-3","article-title":"Tomisaku Kawasaki and Kawasaki disease.","volume":"38","author":"S Yale","year":"2022","journal-title":"Childs Nerv. Syst."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/12-235\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-235\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/12-235\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T05:56:38Z","timestamp":1681365398000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/12-235\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":43,"URL":"https:\/\/doi.org\/10.12688\/f1000research.130169.2","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.145895.r168599","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.145895.r168598","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.145895.r168599","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.145895.r168598","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/12-235\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.145895.r168599, Alhad Mulkalwar, Department of Medicine, Seth Gordhandas Sunderdas Medical College, King Edward Memorial Hospital, Mumbai, Maharashtra, 04 Apr 2023, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/12-235\/v2#referee-response-168599","order":0,"name":"referee-response-168599","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.145895.r168598, Arpit Mago, Department of Clinical Medicine, Jawaharlal Nehru Medical College, Belgaum, Karnataka, 13 Apr 2023, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/12-235\/v2#referee-response-168598","order":1,"name":"referee-response-168598","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}